The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Plasma Albumin and Incident Cardiovascular Disease: Results From the CGPS and an Updated Meta-Analysis
Abstract
Objective: We studied the association of plasma albumin with cardiovascular disease (CVD) and explored potential mechanisms behind the association in the CGPS (Copenhagen General Population Study). We also performed a meta-analysis to summarize the association between plasma albumin and CVD in individuals without preexisting CVD. Approach and Results: We included 100 520 individuals without prior CVD with 8247 incident CVD events developed during a median follow-up of 8.5 years. Rates of CVD outcomes were calculated using Cox regression and Fine and Gray competing-risks regression. The association of plasma albumin and CVD was approximately linear and confounder adjustment had little influence on the effect estimates, except for some attenuation after CRP (C-reactive protein) adjustment. In analyses according to subtypes of CVD events, the hazard ratios for each 10 g/L lower plasma albumin were 1.17 (95% CI, 1.08–1.28) for ischemic heart disease, 1.25 (95% CI, 1.09–1.43) for myocardial infarction, 1.37 (95% CI, 1.21–1.54) for any stroke, and 1.46 (95% CI, 1.28–1.68) for ischemic stroke. In the meta-analysis, we combined estimates from prospective and nested case-control studies investigating the association of plasma albumin with CVD. The meta-analysis included 14 studies with 150 652 individuals (12 studies reported events totaling 11 872). The risk ratio for a CVD event per 10 g/L lower plasma albumin was 1.96 (95% CI, 1.43–2.68) in previous studies and 1.85 (95% CI, 1.39–2.47) including our study with 57% weight in the meta-analysis. Exploratory analyses of the mechanism of the association indicated that it was probably not due to fatty acid binding but may be due to the regulation of plasma albumin by inflammation. Conclusions: There is a robust, independent association of low plasma albumin with CVD, partly explained by plasma albumin as a negative acute-phase reactant. Clinical Trial Registration: URL: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=95796 . Unique identifier: CRD42018095796
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485
INCREASED VASCULAR PERMEABILITY: A MAJOR CAUSE OF HYPOALBUMINAEMIA IN DISEASE AND INJURY
Fleck, A., Hawker, F., Wallace, P. I., Raines, G., Trotter, J., Ledingham, I. M., & Calman, K. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91447-3 · Cited by 898
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons
Corti, M.-C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520130074036 · Cited by 672
Interpreting Incremental Value of Markers Added to Risk Prediction Models
Pencina, M. J., D'Agostino, R. B., Pencina, K. M., Janssens, A. C. J. W., & Greenland, P. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws207 · Cited by 506
Jørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501
Self-citationCorti, M.-C., Salive, M. E., & Guralnik, J. M. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00562-5 · Cited by 107
Cited by
Metabolomic profiles predict individual multidisease outcomes
Buergel, T., Steinfeldt, J., Ruyoga, G., Pietzner, M., Bizzarri, D., Vojinovic, D., Upmeier zu Belzen, J., Loock, L., Kittner, P., Christmann, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01980-3 · Cited by 406
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Low serum albumin: A neglected predictor in patients with cardiovascular disease
Manolis, A. A., Manolis, T. A., Melita, H., Mikhailidis, D. P., & Manolis, A. S. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.004 · Cited by 353
Romero-Cabrera, J. L., Ankeny, J., Fernández-Montero, A., Kales, S. N., & Smith, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113540 · Cited by 63
Metadata
- Authors
- Ronit, A., Kirkegaard-Klitbo, D. M., Dohlmann, T. L., Lundgren, J., Sabin, C. A., Phillips, A. N., Nordestgaard, B. G., & Afzal, S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2020-02
- Volume
- 40
- Issue
- 2
- Pages
- 473-482
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2996355084
- Cited by
- 204
- References
- 16
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.